Opiates Confirmation, Quantitative, Urine


Abbrev Code:UOPIQT   
Order Code:LAB1245Order Name:Opiates Quantitative Urine
Order Instructions:Preferred test to follow-up presumptive results.
Synonyms:Codeine; Morphine
Methodology:Quantitative liquid chromatography-Tandem mass spectrometry
CPT Codes: 80361 x1, 80361 x1
Test Includes:Refer to information in Reference Range.
Turnaround Time:Specimens are sent to the reference laboratory Sun-Sat; results are reported within 1-4 days.
Compliance:

ARUP Laboratory Developed Test (LDT): For tests developed and validated by ARUP (previously referred to as Compliance Statement B, C or D). This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.

Associated Links:

Urine Collection Procedure



Collection Instructions

Specimen:Urine, random collection
Optimal Volume:Submit entire collection.
Minimum\Peds Volume:0.3 mL
Container:Plastic leakproof container, sterile
Causes for Rejection:Specimens exposed to repeated freeze/thaw cycles.


Processing and Shipping

Specimen Processing:Mix collection well before aliquot is taken. Aliquot 0.5 mL, 0.3 mL minimum. Store at room temperature.
Shipping Instructions:Ship at room temperature.
Stability:1 week at room temperature; 1 month refrigerated; 3 years frozen.
Test Performed at or Referral Lab Lab Sendouts  (ARUP)
Referral Lab number:0090364


Interpretive

Reference Range:
Drugs Covered Cutoff
Concentrations
Codeine 20 ng/mL
Morphine 20 ng/mL
6-acetylmorphine 10 ng/mL
Hydrocodone 20 ng/mL
Norhydrocodone 20 ng/mL
Hydromorphone 20 ng/mL
Oxycodone 20 ng/mL
Norxycodone 20 ng/mL
Oxymorphone 20 ng/mL
Noroxymorphone 20 ng/mL
For medical purposes only; not valid for forensic use. Identification of specific drug(s) taken by specimen donor is problematic due to common metabolites, some of which are prescription drugs themselves. The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. All drug analytes covered are in the non-glucuronidated (free) forms. The concentration value must be greater than or equal to the cutoff to be reported as positive. A very small amount of an , drug analyte in the presence of a large amount of an expected drug analyte may reflect pharmaceutical impurity. Interpretive questions should be directed to the laboratory
 


Click HERE to Report test errors or omissions.
*If no email program is associated with this computer, please contact:
systemlabguide@fairview.org for TestID: 6233"